Report Update Nov 1, 2024

Romania - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights

Single report

Sent by email within 24h (Mon-Fri)

$599 Basic Edition

$2095 Professional Edition

What's the difference?

Subscription

Online access and download

from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Romania: Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Market Size in Romania

In 2021, the Romanian medicaments containing insulin market was finally on the rise to reach $X after two years of decline. Overall, consumption continues to indicate a perceptible increase. As a result, consumption reached the peak level of $X. From 2019 to 2021, the growth of the market remained at a somewhat lower figure.

Medicaments Containing Insulin Production in Romania

In value terms, medicaments containing insulin production contracted significantly to $X in 2021 estimated in export price. In general, production saw a resilient increase. The pace of growth appeared the most rapid in 2020 when the production volume increased by 493% against the previous year. As a result, production reached the peak level of $X, and then contracted notably in the following year.

Medicaments Containing Insulin Exports

Exports from Romania

Medicaments containing insulin exports from Romania skyrocketed to X kg in 2021, picking up by 147% on the previous year. In general, exports posted a significant expansion. The most prominent rate of growth was recorded in 2020 when exports increased by 352%. The exports peaked in 2021 and are expected to retain growth in years to come.

In value terms, medicaments containing insulin exports surged to $X in 2021. Over the period under review, exports continue to indicate significant growth. As a result, the exports reached the peak and are likely to continue growth in the immediate term.

Exports by Country

The Czech Republic (X kg) was the main destination for medicaments containing insulin exports from Romania, with a 96% share of total exports. It was followed by Ireland (X kg), with a 2.2% share of total exports.

From 2013 to 2021, the average annual rate of growth in terms of volume to the Czech Republic was relatively modest. Exports to the other major destinations recorded the following average annual rates of exports growth: Ireland (+16.7% per year) and Germany (-21.6% per year).

In value terms, the Czech Republic ($X) emerged as the key foreign market for medicaments containing insulin but not antibiotics exports from Romania, comprising 95% of total exports. The second position in the ranking was taken by Germany ($X), with a 3.2% share of total exports. It was followed by Ireland, with a 1.8% share.

From 2013 to 2021, the average annual rate of growth in terms of value to the Czech Republic amounted to +3,800,877.8%. Exports to the other major destinations recorded the following average annual rates of exports growth: Germany (-9.1% per year) and Ireland (-6.9% per year).

Export Prices by Country

The average medicaments containing insulin export price stood at $X per kg in 2021, therefore, remained relatively stable against the previous year. In general, the export price, however, continues to indicate strong growth. The export price peaked at $X per kg in 2019; however, from 2020 to 2021, the export prices stood at a somewhat lower figure.

There were significant differences in the average prices for the major export markets. In 2021, amid the top suppliers, the country with the highest price was Germany ($X per kg), while the average price for exports to Ireland ($X per kg) was amongst the lowest.

From 2013 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to the UK (+33.0%), while the prices for the other major destinations experienced mixed trend patterns.

Medicaments Containing Insulin Imports

Imports into Romania

In 2019, purchases abroad of medicaments containing insulin but not antibiotics increased by 69% to X kg, rising for the fifth consecutive year after two years of decline. In general, imports posted a significant increase. The growth pace was the most rapid in 2018 when imports increased by 167% against the previous year. Imports peaked in 2019 and are likely to see gradual growth in the immediate term.

In value terms, medicaments containing insulin imports skyrocketed to $X in 2019. Over the period under review, imports saw buoyant growth. The pace of growth was the most pronounced in 2018 when imports increased by 157% against the previous year. Over the period under review, imports hit record highs in 2019 and are likely to see gradual growth in the near future.

Imports by Country

In 2019, the Netherlands (X kg) was the main medicaments containing insulin supplier to Romania, accounting for a approx. 100% share of total imports.

From 2012 to 2019, the average annual rate of growth in terms of volume from the Netherlands amounted to +112.1%.

In value terms, the Netherlands ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics to Romania.

From 2012 to 2019, the average annual rate of growth in terms of value from the Netherlands amounted to +19.2%.

Import Prices by Country

The average medicaments containing insulin import price stood at $X per ton in 2019, dropping by -4.6% against the previous year. Over the period under review, the import price recorded a deep slump. The most prominent rate of growth was recorded in 2015 an increase of 4.3%. As a result, import price attained the peak level of $X per ton. From 2016 to 2019, the average import prices remained at a lower figure.

As there is only one major supplying country, the average price level is determined by prices for the Netherlands.

From 2014 to 2019, the rate of growth in terms of prices for the Netherlands amounted to +68.8% per year.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

What are the largest markets for medicaments containing insulin but not antibiotics in the world?

Denmark remains the largest medicaments containing insulin consuming country worldwide, comprising approx. 58% of total volume. Moreover, medicaments containing insulin consumption in Denmark exceeded the figures recorded by the second-largest consumer, the U.S., sevenfold. Pakistan ranked third in terms of total consumption with a 3.6% share.

What are the largest producers of medicaments containing insulin but not antibiotics in the world?

The U.S. remains the largest medicaments containing insulin producing country worldwide, accounting for 80% of total volume. Moreover, medicaments containing insulin production in the U.S. exceeded the figures recorded by the second-largest producer, Denmark, more than tenfold. The third position in this ranking was occupied by Pakistan, with a 2.5% share.

What are the leading suppliers of medicaments containing insulin but not antibiotics to Romania?

In value terms, the Netherlands constituted the largest supplier of medicaments containing insulin to Romania.

What are the leading importers of medicaments containing insulin but not antibiotics from Romania?

In value terms, the UK remains the key foreign market for medicaments containing insulin exports from Romania, comprising 53% of total exports. The second position in the ranking was occupied by Germany, with a 17% share of total exports. It was followed by the Netherlands, with a 13% share.

What is the average export price for medicaments containing insulin but not antibiotics in Romania?

In 2020, the average medicaments containing insulin export price amounted to $186,886 per ton, increasing by 2.4% against the previous year.

What is the average import price for medicaments containing insulin but not antibiotics in Romania?

In 2017, the average medicaments containing insulin import price amounted to $57,823 per ton, waning by -18% against the previous year.

This report provides an in-depth analysis of the medicaments containing insulin market in Romania. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale

Country coverage:

Romania

Data coverage:

Market volume and value
Per Capita consumption
Forecast of the market dynamics in the medium term
Trade (exports and imports) in Romania
Export and import prices
Market trends, drivers and restraints
Key market players and their profiles

Reasons to buy this report:

Take advantage of the latest data
Find deeper insights into current market developments
Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

How to diversify your business and benefit from new market opportunities
How to load your idle production capacity
How to boost your sales on overseas markets
How to increase your profit margins
How to make your supply chain more sustainable
How to reduce your production and supply chain costs
How to outsource production to other countries
How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business
1. REPORT DESCRIPTION
2. RESEARCH METHODOLOGY AND AI PLATFORM
3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
4. GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance
1. KEY FINDINGS
2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
3. MARKET OVERVIEW

Understanding the Current State of The Market and Its Prospects
1. MARKET SIZE
2. MARKET STRUCTURE
3. TRADE BALANCE
4. PER CAPITA CONSUMPTION
5. MARKET FORECAST TO 2030
4. MOST PROMISING PRODUCT

Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO
1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
2. BEST-SELLING PRODUCTS
3. MOST CONSUMED PRODUCT
4. MOST TRADED PRODUCT
5. MOST PROFITABLE PRODUCT FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO
1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
2. TOP PRODUCING COUNTRIES
3. TOP EXPORTING COUNTRIES
4. LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO
1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
2. TOP CONSUMING MARKETS
3. UNSATURATED MARKETS
4. TOP IMPORTING MARKETS
5. MOST PROFITABLE MARKETS
7. PRODUCTION

The Latest Trends and Insights into The Industry
1. PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
1. IMPORTS FROM 2012–2023
2. IMPORTS BY COUNTRY
3. IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
1. EXPORTS FROM 2012–2023
2. EXPORTS BY COUNTRY
3. EXPORT PRICES BY COUNTRY
10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO
LIST OF TABLES
1. Key Findings In 2023
2. Market Volume, In Physical Terms, 2012–2023
3. Market Value, 2012–2023
4. Per Capita Consumption In 2012-2023
5. Imports, In Physical Terms, By Country, 2012–2023
6. Imports, In Value Terms, By Country, 2012–2023
7. Import Prices, By Country Of Origin, 2012–2023
8. Exports, In Physical Terms, By Country, 2012–2023
9. Exports, In Value Terms, By Country, 2012–2023
10. Export Prices, By Country Of Destination, 2012–2023
LIST OF FIGURES
1. Market Volume, In Physical Terms, 2012–2023
2. Market Value, 2012–2023
3. Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
4. Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
5. Trade Balance, In Physical Terms, 2012-2023
6. Trade Balance, In Value Terms, 2012-2023
7. Per Capita Consumption, 2012-2023
8. Market Volume Forecast to 2030
9. Market Value Forecast to 2030
10. Products: Market Size And Growth, By Type
11. Products: Average Per Capita Consumption, By Type
12. Products: Exports And Growth, By Type
13. Products: Export Prices And Growth, By Type
14. Production Volume And Growth
15. Exports And Growth
16. Export Prices And Growth
17. Market Size And Growth
18. Per Capita Consumption
19. Imports And Growth
20. Import Prices
21. Production, In Physical Terms, 2012–2023
22. Production, In Value Terms, 2012–2023
23. Imports, In Physical Terms, 2012–2023
24. Imports, In Value Terms, 2012–2023
25. Imports, In Physical Terms, By Country, 2023
26. Imports, In Physical Terms, By Country, 2012–2023
27. Imports, In Value Terms, By Country, 2012–2023
28. Import Prices, By Country Of Origin, 2012–2023
29. Exports, In Physical Terms, 2012–2023
30. Exports, In Value Terms, 2012–2023
31. Exports, In Physical Terms, By Country, 2023
32. Exports, In Physical Terms, By Country, 2012–2023
33. Exports, In Value Terms, By Country, 2012–2023
34. Export Prices, By Country Of Destination, 2012–2023